The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis
Open accessAbstract
The modified Rodnan skin score (mRSS) is a measure of skin thickness and is used as a primary or secondary outcome measure in clinical trials of systemic sclerosis (scleroderma). This state-of-art review provides a historical perspective of the development of the mRSS, summarizes the performance of mRSS as an outcome measure, provides guidance on assessing mRSS, and makes recommendations for incorporation of the mRSS into clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cyclophosphamide versus placebo in scleroderma lung disease
Tashkin, D. P., Elashoff, R., Clements, P. J., Goldin, J., Roth, M. D., Furst, D. E., Arriola, E., Silver, R., Strange, C., Bolster, M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055120 · Cited by 1,677
Self-citationCriteria for the classification of early systemic sclerosis.
LeRoy, E. C., & Medsger, T. A. (2001) · PubMed · Cited by 1,384
Self-citationvan Laar, J. M., Farge, D., Sont, J. K., Naraghi, K., Marjanovic, Z., Larghero, J., Schuerwegh, A. J., Marijt, E. W. A., Vonk, M. C., Schattenberg, A. V., et al. (2014) · JAMA · doi:10.1001/jama.2014.6368 · Cited by 766
Self-citationKhanna, D., Denton, C. P., Jahreis, A., van Laar, J. M., Frech, T. M., Anderson, M. E., Baron, M., Chung, L., Fierlbeck, G., Lakshminarayanan, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00232-4 · Cited by 683
Self-citationClements, P., Lachenbruch, P. A., Seibold, J. R., Zee, B. C.-Y., Steen, V. D., Brennan, P., Silman, A. J., Allegar, N. E., Varga, J., & Massa, M. C. (1993) · PubMed · Cited by 449
Self-citationSkin thickness and collagen content in progressive systemic sclerosis and localized scleroderma
Rodnan, G. P., Lipinski, E., & Luksick, J. (1979) · Arthritis & Rheumatism · doi:10.1002/art.1780220205 · Cited by 341
Clements, P. J., Furst, D. E., Wong, W.-K., Mayes, M., White, B., Wigley, F., Weisman, M. H., Barr, W., Moreland, L. W., Medsger Jr., T. A., et al. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199906)42:6<1194::aid-anr16>3.0.co;2-7 · Cited by 330
Self-citationD-Penicillamine Therapy in Progressive Systemic Sclerosis (Scleroderma): A Retrospective Analysis
STEEN, V. D., MEDSGER, T. A., & RODNAN, G. P. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-5-652 · Cited by 322
Self-citationFürst, D. E., Clements, P. J., Steen, V. D., Medsger, T. A., Masi, A. T., D’Angelo, W., Lachenbruch, P. A., Grau, R. G., & Seibold, J. R. (1998) · PubMed · Cited by 277
Self-citationDomsic, R. T., Rodriguez-Reyna, T., Lucas, M., Fertig, N., & Medsger, T. A. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.127621 · Cited by 257
Self-citation
Cited by
Nintedanib for systemic sclerosis–associated interstitial lung disease
Distler, O., Highland, K. B., Gahlemann, M., Azuma, A., Fischer, A., Mayes, M. D., Raghu, G., Sauter, W., Girard, M., Alves, M., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1903076 · Cited by 1,647
Self-citationCD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
Müller, F., Taubmann, J., Bucci, L., Wilhelm, A., Bergmann, C., Völkl, S., Aigner, M., Rothe, T., Minopoulou, I., Tur, C., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2308917 · Cited by 1,095
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
Khanna, D., Lin, C. J. F., Furst, D. E., Goldin, J., Kim, G., Kuwana, M., Allanore, Y., Matucci-Cerinic, M., Distler, O., Shima, Y., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30318-0 · Cited by 662
Self-citationAllogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
Wang, X., Wu, X., Tan, B., Zhu, L., Zhang, Y., Lin, L., Xiao, Y., Sun, A., Wan, X., Liu, S., et al. (2024) · Cell · doi:10.1016/j.cell.2024.06.027 · Cited by 320
Ebata, S., Yoshizaki, A., Oba, K., Kashiwabara, K., Ueda, K., Uemura, Y., Watadani, T., Fukasawa, T., Miura, S., Yoshizaki-Ogawa, A., et al. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(21)00107-7 · Cited by 274
Cheng, C.-Y., Baritussio, A., Giordani, A. S., Iliceto, S., Marcolongo, R., & Caforio, A. L. P. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103037 · Cited by 56
Metadata
- Authors
- Khanna, D., Furst, D. E., Clements, P. J., Allanore, Y., Baron, M., Czirjak, L., Distler, O., Foeldvari, I., Kuwana, M., Matucci-Cerinic, M., Mayes, M., Medsger, T., Merkel, P. A., Pope, J. E., Seibold, J. R., Steen, V., Stevens, W., & Denton, C. P.
- Venue
- Journal of Scleroderma and Related Disorders
- Publisher
- SAGE Publications
- Published
- 2017-01
- Volume
- 2
- Issue
- 1
- Pages
- 11-18
- ISSN
- 2397-1983 (ISSN-L)
- 2397-1991
- OpenAlex
- W2589893823
- Cited by
- 541
- References
- 26
- FWCI
- 25.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.